Bruno Ségui
Impact in
- Oncology top 5%
- Cancer Immunotherapy and Biomarkers
- Molecular Biology top 5%
- Sphingolipid Metabolism and Signaling
- Cell death mechanisms and regulation
Papers in
-
- Sphingolipid Metabolism and Signaling 42
- Cell death mechanisms and regulation 13
- Oncology 15
- Cancer Immunotherapy and Biomarkers 13
- Cytokine Signaling Pathways and Interactions 3
- Co-authors
- Thierry Levade (51 shared papers)Nathalie Andrieu‐Abadie (39 shared papers)Céline Colacios (18 shared papers)Anne Montfort (16 shared papers)Hervé Benoist (25 shared papers)Nicolás Meyer (10 shared papers)Virginie Garcia (14 shared papers)Philippe Rochaix (3 shared papers)
- Journals
- Journal of Biological Chemistry (5 papers)The FASEB Journal (4 papers)PLoS ONE (3 papers)Recent Patents on Anti-Cancer Drug Discovery (2 papers)International Journal of Molecular Sciences (2 papers)
- Partner nations
- FranceUnited StatesSpain
In The Last Decade
Bruno Ségui
85 papers receiving 3k citations
Peers
Comparison fields: 5 of 98
- Oncology 692
- Molecular Biology 1.4k
- Immunology 285
- Cancer Research 186
- Biochemistry 69
Countries citing papers authored by Bruno Ségui
This map shows the geographic impact of Bruno Ségui's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bruno Ségui with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bruno Ségui more than expected).
Fields of papers citing papers by Bruno Ségui
This network shows the impact of papers produced by Bruno Ségui. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bruno Ségui. The network helps show where Bruno Ségui may publish in the future.
Co-authors
The 25 scholars most cited alongside Bruno Ségui, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 85 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2017 | 317 | |
| 2 | 2019 | 236 | |
| 3 | 2006 | 105 | |
| 4 | 2020 | 104 | |
| 5 | 2005 | 100 | |
| 6 | 2001 | 99 | |
| 7 | 2015 | 98 | |
| 8 | 2001 | 88 | |
| 9 | 2007 | 87 | |
| 10 | 2014 | 83 | |
| 11 | 2020 | 83 | |
| 12 | 2002 | 78 | |
| 13 | 2009 | 72 | |
| 14 | 1999 | 62 | |
| 15 | 2006 | 60 | |
| 16 | 2020 | 58 | |
| 17 | 2002 | 55 | |
| 18 | 2000 | 52 | |
| 19 | 2011 | 51 | |
| 20 | 2013 | 51 |
About Bruno Ségui
Bruno Ségui is a scholar working on Molecular Biology, Oncology, Immunology, Transplantation and Physiology, having authored 85 papers that have together received 3k indexed citations. Recurring topics across this work include Sphingolipid Metabolism and Signaling (42 papers), Cancer Immunotherapy and Biomarkers (13 papers), Cell death mechanisms and regulation (13 papers), Lysosomal Storage Disorders Research (6 papers), Transplantation: Methods and Outcomes (6 papers), Cytokine Signaling Pathways and Interactions (3 papers), Immune cells in cancer (3 papers) and Organ and Tissue Transplantation Research (3 papers). The work is most often cited by research in Oncology (692 citations), Molecular Biology (1.4k citations), Immunology (285 citations), Cancer Research (186 citations) and Biochemistry (69 citations). Bruno Ségui has collaborated with scholars based in France, United States and Spain. Frequent co-authors include Thierry Levade, Nathalie Andrieu‐Abadie, Céline Colacios, Anne Montfort, Hervé Benoist, Nicolás Meyer, Virginie Garcia, Philippe Rochaix, Shamshad Cockcroft and Victoria Allen-Baume. Their work appears in journals such as Journal of Biological Chemistry, The FASEB Journal, PLoS ONE, Recent Patents on Anti-Cancer Drug Discovery and International Journal of Molecular Sciences.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.